Browsing Tag
Neuvis
1 post
Argent BioPharma (ASX: RGT) acquires AusCann assets in $15m deal — can it unlock U.S. listing potential?
Argent BioPharma acquires AusCann assets in a $15M deal to expand its clinical pipeline, strengthen EU infrastructure, and advance toward a U.S. listing.